BibTex RIS Kaynak Göster

Onychomycosis Case Developing during Interferon Treatment

Yıl 2013, Cilt: 2013 Sayı: 1, - , 01.01.2013

Nazan Tuna Mustafa Teoman Erdem Oğuz Karabay

https://doi.org/10.5152/balkanmedj.2012.115

Öz

universalis secondary to PEG-interferon alpha-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus in- fection. Eur J Gastroenterol Hepatol 2007;19:817-20. [CrossRef]

Anahtar Kelimeler

-

Kaynakça

  • Kwon H, Lok AS. Hepatitis B therapy. Nat Rev Gastroenterol Hep- atol 2011;8:275-84.
  • Chang LW, Liranzo M, Bergfeld WF. Cutaneous side effects asso- ciated with interferon alpha therapy:a review. Cutis 1995;56:144.
  • Dereure O, Raison-Peyron N, Larrey D, Blanc F, Guilhou JJ. Dif- fuse inflammatory lesions in patients treated with interferon alfa and ribavirin for hepatitis C:a series of 20 patients. Br J Dermatol 2002;147:1142-6. [CrossRef]
  • Kartal ED, Colak H, Ozgunes I, Usluer G. Exacerbation of psoriasis due to peginterferon alpha-2b plus ribavirin treatment of chronic active hepatitis C. Chemotherapy 2005;51:167-9. [CrossRef]
  • Vázquez-López F, Manjón-Haces JA, Pérez-Alvarez R, Pérez-Oli- va N. Eczema-like lesions and disruption of therapy in patients treated with interferon-alfa and ribavirin for chronic hepatitis C:the value of an interdisciplinary assessment. Br J Dermatol 2004;150:1046-7. [CrossRef]
  • Kartal ED, Alpat SN, Ozgunes I, Usluer G. Reversible alopecia universalis secondary to PEG-interferon alpha-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus in- fection. Eur J Gastroenterol Hepatol 2007;19:817-20. [CrossRef]
  • Koga T, Shimizu A, Nakayama J. Interferon-gamma production in peripheral lymphocytes of patients with tinea pedis:comparison of patients with and without tinea unguium. Med Mycol 2001;39:87-90. [CrossRef]
  • Koga T. Fungal immunology in the skin;immune response to derma- tophytes. Nippon Ishinkin Gakkai Zasshi 2009;50:151-4. [CrossRef]
  • Grover C, Khurana A. Onychomycosis:Newer insights in patho- genesis and diagnosis. Indian J Dermatol Venereol Leprol 2012;78:263-70. [CrossRef]
  • Rosenthal SA, Stritzler R, Vilafane J. Onychomycosis caused by Aspergillus fumigatus. Report of a case. Arch Dermatol 1968;97:685-7. [CrossRef]
  • Ramos A, Ussetti P, Laporta R, Lazaro MT, Sanchez- Romero I. Cutaneous aspergillosis in a lung transplant recipient. Transplant Infect Dis 2009;11:471-3. [CrossRef] Balkan Med J 2013; 30: 131-2
  • Isolated Left Ventricular Diverticulum
  • Figure 3. Six months after discontinuation of therapy

Onychomycosis Case Developing during Interferon Treatment

Yıl 2013, Cilt: 2013 Sayı: 1, - , 01.01.2013

Nazan Tuna Mustafa Teoman Erdem Oğuz Karabay

https://doi.org/10.5152/balkanmedj.2012.115

Öz

-

Anahtar Kelimeler

-

Kaynakça

  • Kwon H, Lok AS. Hepatitis B therapy. Nat Rev Gastroenterol Hep- atol 2011;8:275-84.
  • Chang LW, Liranzo M, Bergfeld WF. Cutaneous side effects asso- ciated with interferon alpha therapy:a review. Cutis 1995;56:144.
  • Dereure O, Raison-Peyron N, Larrey D, Blanc F, Guilhou JJ. Dif- fuse inflammatory lesions in patients treated with interferon alfa and ribavirin for hepatitis C:a series of 20 patients. Br J Dermatol 2002;147:1142-6. [CrossRef]
  • Kartal ED, Colak H, Ozgunes I, Usluer G. Exacerbation of psoriasis due to peginterferon alpha-2b plus ribavirin treatment of chronic active hepatitis C. Chemotherapy 2005;51:167-9. [CrossRef]
  • Vázquez-López F, Manjón-Haces JA, Pérez-Alvarez R, Pérez-Oli- va N. Eczema-like lesions and disruption of therapy in patients treated with interferon-alfa and ribavirin for chronic hepatitis C:the value of an interdisciplinary assessment. Br J Dermatol 2004;150:1046-7. [CrossRef]
  • Kartal ED, Alpat SN, Ozgunes I, Usluer G. Reversible alopecia universalis secondary to PEG-interferon alpha-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus in- fection. Eur J Gastroenterol Hepatol 2007;19:817-20. [CrossRef]
  • Koga T, Shimizu A, Nakayama J. Interferon-gamma production in peripheral lymphocytes of patients with tinea pedis:comparison of patients with and without tinea unguium. Med Mycol 2001;39:87-90. [CrossRef]
  • Koga T. Fungal immunology in the skin;immune response to derma- tophytes. Nippon Ishinkin Gakkai Zasshi 2009;50:151-4. [CrossRef]
  • Grover C, Khurana A. Onychomycosis:Newer insights in patho- genesis and diagnosis. Indian J Dermatol Venereol Leprol 2012;78:263-70. [CrossRef]
  • Rosenthal SA, Stritzler R, Vilafane J. Onychomycosis caused by Aspergillus fumigatus. Report of a case. Arch Dermatol 1968;97:685-7. [CrossRef]
  • Ramos A, Ussetti P, Laporta R, Lazaro MT, Sanchez- Romero I. Cutaneous aspergillosis in a lung transplant recipient. Transplant Infect Dis 2009;11:471-3. [CrossRef] Balkan Med J 2013; 30: 131-2
  • Isolated Left Ventricular Diverticulum
  • Figure 3. Six months after discontinuation of therapy
Toplam 13 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Bölüm Makaleler
Yazarlar

Nazan Tuna Bu kişi benim

Mustafa Teoman Erdem Bu kişi benim

Oğuz Karabay Bu kişi benim

Yayımlanma Tarihi 1 Ocak 2013
Yayımlandığı Sayı Yıl 2013 Cilt: 2013 Sayı: 1

Kaynak Göster

APA Tuna, N., Erdem, M. T., & Karabay, O. (2013). Onychomycosis Case Developing during Interferon Treatment. Balkan Medical Journal, 2013(1). https://doi.org/10.5152/balkanmedj.2012.115
AMA Tuna N, Erdem MT, Karabay O. Onychomycosis Case Developing during Interferon Treatment. Balkan Medical Journal. Ocak 2013;2013(1). doi:10.5152/balkanmedj.2012.115
Chicago Tuna, Nazan, Mustafa Teoman Erdem, ve Oğuz Karabay. “Onychomycosis Case Developing During Interferon Treatment”. Balkan Medical Journal 2013, sy. 1 (Ocak 2013). https://doi.org/10.5152/balkanmedj.2012.115.
EndNote Tuna N, Erdem MT, Karabay O (01 Ocak 2013) Onychomycosis Case Developing during Interferon Treatment. Balkan Medical Journal 2013 1
IEEE N. Tuna, M. T. Erdem, ve O. Karabay, “Onychomycosis Case Developing during Interferon Treatment”, Balkan Medical Journal, c. 2013, sy. 1, 2013, doi: 10.5152/balkanmedj.2012.115.
ISNAD Tuna, Nazan vd. “Onychomycosis Case Developing During Interferon Treatment”. Balkan Medical Journal 2013/1 (Ocak 2013). https://doi.org/10.5152/balkanmedj.2012.115.
JAMA Tuna N, Erdem MT, Karabay O. Onychomycosis Case Developing during Interferon Treatment. Balkan Medical Journal. 2013;2013. doi:10.5152/balkanmedj.2012.115.
MLA Tuna, Nazan vd. “Onychomycosis Case Developing During Interferon Treatment”. Balkan Medical Journal, c. 2013, sy. 1, 2013, doi:10.5152/balkanmedj.2012.115.
Vancouver Tuna N, Erdem MT, Karabay O. Onychomycosis Case Developing during Interferon Treatment. Balkan Medical Journal. 2013;2013(1).